Astera Labs (NASDAQ:ALAB) Upgraded to “Strong-Buy” at Zacks Research

Astera Labs (NASDAQ:ALAB) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

Several other analysts have also issued reports on the company. Roth Capital restated a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Rothschild & Co Redburn began coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. TD Cowen lowered their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. Finally, Susquehanna upped their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $325.25.

Astera Labs Stock Up 2.2%

Astera Labs stock opened at $318.80 on Tuesday. The firm has a 50 day moving average price of $358.62 and a 200-day moving average price of $238.55. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market capitalization of $55.31 billion, a P/E ratio of 157.82 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the previous year, the firm posted $0.44 EPS. Astera Labs’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts expect that Astera Labs will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $1,092,964.15. Following the completion of the transaction, the director directly owned 53,961 shares in the company, valued at approximately $16,826,658.63. The trade was a 6.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the sale, the director owned 5,550 shares in the company, valued at approximately $2,192,472. The trade was a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,256,894 shares of company stock worth $362,763,135. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently modified their holdings of ALAB. Royal Bank of Canada boosted its position in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares during the period. AQR Capital Management LLC increased its holdings in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the period. Empowered Funds LLC lifted its stake in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares in the last quarter. First Trust Advisors LP lifted its stake in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its stake in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after purchasing an additional 1,977 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Brokerages assign ALAB a consensus “Moderate Buy” rating, indicating generally favorable views among covering analysts. Astera Labs Given Consensus Recommendation of Moderate Buy
• Positive Sentiment: Northland Securities substantially raised its earnings forecasts, including FY2026 EPS to $2.75 from $1.82 and FY2027 EPS to $5.43 from $2.26. The revisions reflect expectations for strong growth in Astera’s AI connectivity business. Northland Securities Earnings Estimate Revisions
• Positive Sentiment: Analyst commentary highlights record growth, rising PCIe 6 demand and an expanding connectivity portfolio, potentially helping Astera compete with Marvell and Credo. ALAB Benefits From PCIe Demand
• Positive Sentiment: A bullish Seeking Alpha analysis sees Astera’s shift toward integrated, rack-level connectivity as an inflection point. Its Scorpio high-radix fabric switch could become the company’s largest revenue source, increase average selling prices and support cross-selling. The article assigns a Buy rating and a $370 price target. Astera Labs AI Fabric Inflection
• Positive Sentiment: AMD’s planned Helios rack-scale AI systems could benefit Astera as an ecosystem supplier, adding another potential demand driver beyond direct accelerator vendors. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Despite raising its earnings estimates, Northland Securities maintained a “Market Perform” rating, signaling that strong growth expectations may already be reflected in ALAB’s valuation.
• Negative Sentiment: Astera Labs trades at a very high valuation, with a reported P/E ratio near 158 and a beta of 3.84. This leaves the stock particularly sensitive to profit-taking, changes in AI spending expectations and broader technology-sector weakness.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.